| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.31 | 1e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.29 | 3e-07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.2 | 6e-07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-06 |